Radium-223 in Metastatic Castration-Resistant Prostate Cancer: Single-Institution Analysis of Factors Associated With Treatment Completion and Survival

被引：0
|
作者：
Bang, A. [1 ]
Malone, S. [1 ]
Leung, E. Y. C. [2 ]
Canil, C. [1 ]
Eapen, L. [1 ]
Morgan, S. C. [1 ]
机构：
[1] Ottawa Hosp, Ctr Canc, Ottawa, ON, Canada
[2] Ottawa Hosp, Ottawa, ON, Canada
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2016年 / 96卷 / 02期
关键词：
D O I：
10.1016/j.ijrobp.2016.06.1276
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2633
引用
收藏
页码：E260 / E261
页数：2
相关论文
共 50 条
  • [31] Radium-223 Dichloride in Peritoneal Dialysate Following Treatment of Metastatic Castration-resistant Prostate Cancer
    Saganich, Christopher
    Zgaljardic, Michael
    HEALTH PHYSICS, 2022, 122 (03): : 433 - 439
  • [32] Acute Promyelocytic Leukemia After Treatment of Metastatic Castration-Resistant Prostate Cancer With Radium-223
    Odo, Ugochukwu
    Vasudevamurthy, Ashwin K.
    Sartor, Oliver
    CLINICAL GENITOURINARY CANCER, 2017, 15 (03) : E501 - E502
  • [33] Treatment intensification with radium-223 plus enzalutamide in patients with metastatic castration-resistant prostate cancer
    Shore, Neal
    Carles, Joan
    McDermott, Ray
    Agarwal, Neeraj
    Tombal, Bertrand
    FRONTIERS IN MEDICINE, 2024, 11
  • [34] Impact of treatment delay in Radium-223 therapy of metastatic castration-resistant prostate cancer patients
    Fosbol, Marie Obro
    Petersen, Peter Meidahl
    Daugaard, Gedske
    Holm, Soren
    Kjaer, Andreas
    Mortensen, Jann
    ANNALS OF NUCLEAR MEDICINE, 2018, 32 (01) : 16 - 21
  • [35] Impact of treatment delay in Radium-223 therapy of metastatic castration-resistant prostate cancer patients
    Marie Øbro Fosbøl
    Peter Meidahl Petersen
    Gedske Daugaard
    Søren Holm
    Andreas Kjaer
    Jann Mortensen
    Annals of Nuclear Medicine, 2018, 32 : 16 - 21
  • [36] Radionuclide Therapies in Prostate Cancer: Integrating Radium-223 in the Treatment of Patients With Metastatic Castration-Resistant Prostate Cancer
    Nilsson, Sten
    CURRENT ONCOLOGY REPORTS, 2016, 18 (02) : 1 - 12
  • [37] The Timing of Radium-223 Therapy in Castration-Resistant Prostate Cancer
    Sartor, Oliver
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2015, 13 (09) : 570 - 572
  • [38] Radionuclide Therapies in Prostate Cancer: Integrating Radium-223 in the Treatment of Patients With Metastatic Castration-Resistant Prostate Cancer
    Sten Nilsson
    Current Oncology Reports, 2016, 18
  • [39] A population-based study of the use of radium 223 in metastatic castration-resistant prostate cancer: Factors associated with treatment completion
    Parimi, Sunil
    Tsang, Erica
    Alexander, Abraham
    McKenzie, Michael
    Bachand, Francois
    Sunderland, Katherine
    Chi, Kim N.
    Aparicio, Maria
    Worsley, Daniel
    Tyldesley, Scott
    CUAJ-CANADIAN UROLOGICAL ASSOCIATION JOURNAL, 2017, 11 (10): : 350 - 355
  • [40] Editorial Comment: Overall survival prediction in metastatic castration-resistant prostate cancer treated with radium-223
    dos Reis, Rodolfo Borges
    Muglia, Valdair
    Faria, Eliney F.
    INTERNATIONAL BRAZ J UROL, 2020, 46 (04): : 612 - 613
12345